W. Koizumi, S. Tanabe, K. Nakatani
Nov 3, 2009
Citations
0
Influential Citations
9
Citations
Quality indicators
Journal
Journal of Clinical Pharmacy and Therapeutics
Abstract
Background and object: An antiulcer agent, ecabet sodium, is active against Helicobacter pylori. The aim of the present study was to clinically examine whether eradication therapy, which includes ecabet sodium, is effective in eradication of H. pylori after failure of first‐line therapy.